HomeIMCR • NASDAQ
add
Immunocore Holdings PLC - ADR
Nakaraang pagsara
$29.52
Sakop ng araw
$29.40 - $30.20
Sakop ng taon
$27.47 - $40.71
Market cap
1.52B USD
Average na Volume
412.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 104.48M | 24.30% |
Gastos sa pagpapatakbo | 289.01M | 21.10% |
Net na kita | -30.06M | -26.46% |
Net profit margin | -28.77 | -1.73% |
Kita sa bawat share | -0.60 | -27.66% |
EBITDA | 871.00K | 470.64% |
Aktuwal na % ng binabayarang buwis | -90.33% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 864.15M | 5.34% |
Kabuuang asset | 1.07B | 5.72% |
Kabuuang sagutin | 686.24M | 5.77% |
Kabuuang equity | 381.03M | — |
Natitirang share | 50.70M | — |
Presyo para makapag-book | 3.93 | — |
Return on assets | 0.01% | — |
Return on capital | 0.01% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -30.06M | -26.46% |
Cash mula sa mga operasyon | -32.66M | -134.07% |
Cash mula sa pag-invest | -880.00K | 75.14% |
Cash mula sa financing | 4.28M | 108.32% |
Net change in cash | -30.70M | 62.57% |
Malayang cash flow | 78.53M | 869.80% |
Tungkol
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
Itinatag
2008
Website
Mga Empleyado
524
